However, TNF blockade had only minor effects on the expression and secretion of IL-6, contrary to what observed in RA patients.30 These data suggest that this cytokine may be more relevant to RA, but less to SpA pathogenesis, consistent with the limited therapeutic efficacy of IL-6-blockade in SpA.31 Here, TNF is linked to rheumatoid arthritis.